{"id":"NCT04317040","sponsor":"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","briefTitle":"Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-04-24","primaryCompletion":"2020-10-20","completion":"2020-10-20","firstPosted":"2020-03-20","resultsPosted":"2021-10-15","lastUpdate":"2023-02-08"},"enrollment":234,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Coronavirus Disease 2019 (COVID-19)"],"interventions":[{"type":"DRUG","name":"Efprezimod alfa","otherNames":["Human CD24","Human IgG Fc Fusion Protein","MK-7110"]},{"type":"DRUG","name":"Placebo","otherNames":["Saline"]}],"arms":[{"label":"Efprezimod alfa","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study evaluates the efficacy and safety of efprezimod alfa in hospitalized adult participants who are diagnosed with coronavirus disease 2019 (COVID-19) and receiving oxygen support.\n\nThe primary hypothesis of the study is clinical improvement in the experimental group versus the control group.","primaryOutcome":{"measure":"Time to Improvement in Coronavirus Disease 2019 (COVID-19) Clinical Status","timeFrame":"Up to Day 29","effectByArm":[{"arm":"CD24Fc","deltaMin":6,"sd":null},{"arm":"Placebo","deltaMin":10.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0367"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["24996822","21208791","21478876","19264983","29983395","32382131","35286843","35012610"],"seeAlso":["http://merckoncologyclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":114},"commonTop":[]}}